APOE and Alzheimer disease: Notably, among all targets with significant association with neurodegeneration, only SQSTM1 withstood corrections for age, sex, and APOE ε4 genotype, revealing it as a potentially novel neurodegeneration biomarker for AD, with respect to cortical thickness.